P. Steindorfer

818 total citations
41 papers, 573 citations indexed

About

P. Steindorfer is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, P. Steindorfer has authored 41 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Cancer Research and 9 papers in Genetics. Recurrent topics in P. Steindorfer's work include Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (12 papers) and HER2/EGFR in Cancer Research (6 papers). P. Steindorfer is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (12 papers) and HER2/EGFR in Cancer Research (6 papers). P. Steindorfer collaborates with scholars based in Austria, Germany and United States. P. Steindorfer's co-authors include H. Hausmaninger, E. Kubista, Michael Gnant, R. Jakesz, Michael Fridrik, Brigitte Mlineritsch, Hellmut Samonigg, W. Kwasny, Michael Seifert and K. Haider and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and International Journal of Cancer.

In The Last Decade

P. Steindorfer

35 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Steindorfer Austria 11 308 285 220 111 102 41 573
R. Bracci Italy 16 173 0.6× 337 1.2× 66 0.3× 184 1.7× 350 3.4× 42 768
Natalie Jones United States 14 258 0.8× 394 1.4× 222 1.0× 243 2.2× 111 1.1× 19 901
Heran Deng China 13 216 0.7× 262 0.9× 49 0.2× 81 0.7× 91 0.9× 31 577
Denise Barbuto United States 17 78 0.3× 90 0.3× 108 0.5× 158 1.4× 104 1.0× 20 857
F Cusumano Italy 9 416 1.4× 214 0.8× 77 0.3× 192 1.7× 81 0.8× 19 724
Michele Valente Italy 19 97 0.3× 149 0.5× 72 0.3× 121 1.1× 125 1.2× 61 820
M. Frikha Tunisia 13 114 0.4× 398 1.4× 34 0.2× 250 2.3× 175 1.7× 71 724
Vilija N. Avizonis United States 11 150 0.5× 230 0.8× 113 0.5× 300 2.7× 177 1.7× 11 711
Jiwon Lim South Korea 16 69 0.2× 240 0.8× 60 0.3× 185 1.7× 168 1.6× 40 630
G. P. Breitbach Germany 10 125 0.4× 222 0.8× 50 0.2× 330 3.0× 105 1.0× 36 685

Countries citing papers authored by P. Steindorfer

Since Specialization
Citations

This map shows the geographic impact of P. Steindorfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Steindorfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Steindorfer more than expected).

Fields of papers citing papers by P. Steindorfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Steindorfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Steindorfer. The network helps show where P. Steindorfer may publish in the future.

Co-authorship network of co-authors of P. Steindorfer

This figure shows the co-authorship network connecting the top 25 collaborators of P. Steindorfer. A scholar is included among the top collaborators of P. Steindorfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Steindorfer. P. Steindorfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jakesz, R., Hellmut Samonigg, Michael Gnant, et al.. (2003). Significant Increase in Breast Conservation in 16 Years of Trials Conducted by the Austrian Breast & Colorectal Cancer Study Group. Annals of Surgery. 237(4). 556–564. 23 indexed citations
3.
Ploner, F., R. Jakesz, H. Hausmaninger, et al.. (2003). Randomised Trial: One Cycle of Anthracycline-Containing Adjuvant Chemotherapy Compared with Six Cycles of CMF Treatment in Node-Positive, Hormone Receptor-Negative Breast Cancer Patients. Oncology Research and Treatment. 26(2). 115–119. 3 indexed citations
4.
Egger, G., Roswitha Pfragner, Veronika Siegl, et al.. (2000). The affinity of MCF7 breast cancer cells to hyaluronan substrates of different molecular weight and concentrations in an in vitro model.. International Journal of Oncology. 17(5). 1019–23. 2 indexed citations
5.
Jakesz, R., H. Hausmaninger, K. Haider, et al.. (1999). Randomized Trial of Low-Dose Chemotherapy Added to Tamoxifen in Patients With Receptor-Positive and Lymph Node–Positive Breast Cancer. Journal of Clinical Oncology. 17(6). 1701–1701. 28 indexed citations
6.
Hofer, H. P., et al.. (1996). The influence of trauma on changes in neutrophil granulocyte function assessed by an analysis of granulocyte migration. Langenbeck s Archives of Surgery. 381(3). 148–54. 4 indexed citations
7.
Uranüs, S., Hans‐Jörg Mischinger, Johann Pfeifer, et al.. (1996). Hemostatic Methods for the Management of Spleen and Liver Injuries. World Journal of Surgery. 20(8). 1107–1112. 43 indexed citations
8.
Pakisch, B., et al.. (1995). Results of irradiation treatment in patients with non-resectable oesophageal cancer. European Journal of Surgical Oncology. 21(6). 627–631. 3 indexed citations
9.
Häuser, H., et al.. (1995). [Epithelioid leiomyosarcoma of the stomach. Clinical experiences with a rare stomach tumor].. PubMed. 107(23). 748–51.
10.
Stöger, Herbert, Thomas Bauernhofer, Robert H. Moser, et al.. (1994). [Breast cancer in the man: a report of 30 patients].. PubMed. 106(18). 575–80. 2 indexed citations
11.
Stöger, Herbert, Marianne Schmid, Thomas Bauernhofer, et al.. (1994). A Phase II Trial of Weekly High-Dose Folinic Acid and 5-Fluorouracil in Combination with Epirubicin as Salvage Chemotherapy in Advanced Breast Cancer. Oncology. 51(6). 518–522. 3 indexed citations
12.
Bauernhofer, Thomas, Marianne Schmid, Ferdinand Ploner, et al.. (1994). A phase I/II study of 4?-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients. Cancer Chemotherapy and Pharmacology. 35(2). 174–178. 1 indexed citations
13.
Schneider, G, P. Steindorfer, & R. Fötter. (1992). Der Stellenwert der Mammographie nach brusterhaltender Therapie des Mammakarzinoms. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 156(6). 582–586. 4 indexed citations
14.
Lind, P., M.G. Smola, P. Lechner, et al.. (1991). The immunoscintigraphic use of Tc‐99m‐labelled monoclonal anti‐CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer. International Journal of Cancer. 47(6). 865–869. 27 indexed citations
15.
Samonigg, Hellmut, Marianne Schmid, Karl Pfeiffer, et al.. (1991). Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer. Cancer Chemotherapy and Pharmacology. 27(6). 477–480. 4 indexed citations
16.
Klimpfinger, M., et al.. (1990). Expression of c-myc and c-fos mRNA in colorectal carcinoma in man. Virchows Archiv B Cell Pathology Including Molecular Pathology. 59(1). 165–171. 19 indexed citations
17.
Samonigg, Hellmut, Herbert Stöger, Marianne Schmid, et al.. (1990). 4′-O-Tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study. Cancer Chemotherapy and Pharmacology. 26(4). 293–296. 7 indexed citations
18.
Schmid, Christoph, et al.. (1990). Non-functional malignant paraganglioma of the stomach. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 417(3). 261–266. 15 indexed citations
19.
Steindorfer, P., R Jakse, R. Germann, et al.. (1987). Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region.. PubMed. 163(7). 449–52. 5 indexed citations
20.
Steindorfer, P., et al.. (1982). [Clinical features and therapeutic management of male breast cancer (author's transl)].. PubMed. 94(7). 172–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026